Who
William P. Mr. Burke
Director
Company insider
Files Form 4 as: Director, Axogen; Director, Miromatrix Medical; Chief Financial Officer, ViewRay; EVP, Chief Financial Officer, Haemonetics.
In numbers
- Trades disclosed
- 137
- Buys
- 2
- Sells
- 37
- Bought
- $116K
- Sold
- $17.6M
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 25 Oct 2016
- Last trade
- 24 Jun 2026
- Last filed
- 26 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 26 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,392 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,392 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —14,150 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —14,150 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —14,150 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —14,150 at $0.00 | filing |
| 11 Nov 2025filed 13 Nov 2025 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,591 at $0.00 | filing |
| 11 Nov 2025filed 13 Nov 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $29K3,591 at $8.14 | filing |
| 11 Nov 2025filed 13 Nov 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $86K3,591 at $24.02 | filing |
| 10 Nov 2025filed 13 Nov 2025 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —19,227 at $0.00 | filing |
| 10 Nov 2025filed 13 Nov 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $157K19,227 at $8.14 | filing |
| 10 Nov 2025filed 13 Nov 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $462K19,227 at $24.01 | filing |
| 6 Nov 2025filed 7 Nov 2025 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,347 at $0.00 | filing |
| 6 Nov 2025filed 7 Nov 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $44K5,347 at $8.14 | filing |
| 6 Nov 2025filed 7 Nov 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $128K5,347 at $24.01 | filing |
| 5 Nov 2025filed 7 Nov 2025 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —11,431 at $0.00 | filing |
| 5 Nov 2025filed 7 Nov 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $93K11,431 at $8.14 | filing |
| 5 Nov 2025filed 7 Nov 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $275K11,431 at $24.05 | filing |
| 30 Oct 2025filed 31 Oct 2025 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —18,248 at $0.00 | filing |
| 30 Oct 2025filed 31 Oct 2025 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $128K18,248 at $7.04 | filing |
News
Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)AXGN · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name William P. Mr. Burke; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.